Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional Analysis.
Taoping Shi, Qingbo Huang, Kan Liu...
https://pubmed.ncbi.nlm.nih.gov/32305170/Actively Recruiting
Led by Peking University Third Hospital · Updated on 2023-02-21
232
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to create a preoperative imaging diagnostic model that closely matches the results of histopathological examinations for patients with renal cell carcinoma RCC that has tumor thrombus invading the inferior vena cava IVC vascular wall. The study also seeks to develop an accurate and systematic pathological grading standard for IVC vascular wall invasion. It will explore how different layers of vascular wall invasion affect long-term prognosis and clinical treatment decisions in RCC with IVC tumor thrombus. The study includes patients diagnosed with primary RCC with IVC tumor thrombus who undergo radical nephrectomy and at least one form of IVC thrombectomy. Participants are divided into two groups based on pathological examination results those with IVC vascular wall invasion invaded group and those without non-invaded group. The study will analyze imaging tests such as abdominal ultrasound, contrast-enhanced ultrasonography, CT, and MRI to identify features of vascular wall invasion and establish a reliable preoperative diagnostic model aligned with pathological findings. Participants will be followed for three years to assess outcomes including local and distant recurrence, overall survival, and recurrence-free survival. Researchers will collect data from preoperative imaging, surgical details, pathological specimens, and postoperative recovery. Multiple clinical and imaging assessments will be conducted before surgery, with long-term monitoring of tumor metastasis and patient health status. This comprehensive follow-up aims to inform better preoperative treatment strategies and surgical planning for RCC patients with IVC tumor thrombus.
CONDITIONS
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion
J
Jiyuan Chen, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peking University Third Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 week
Participants undergo preoperative imaging including abdominal ultrasound, contrast-enhanced ultrasonography, CT, and MRI to assess tumor thrombus and vascular wall invasion.
1 to 2 visits depending on imaging assessments
Duration - Approximately 10 days
Participants receive radical nephrectomy and thrombectomy with pathological examination of tumor thrombus and vascular wall specimens.
1 hospital stay for surgery and immediate postoperative care
Duration - Up to 3 years
Participants are followed up to monitor clinical outcomes including recurrence, survival, and complications after surgery.
Periodic visits for follow-up assessments over 3 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Taoping Shi, Qingbo Huang, Kan Liu...
https://pubmed.ncbi.nlm.nih.gov/32305170/Ronney Abaza
https://pubmed.ncbi.nlm.nih.gov/20846783/Zhaonan Sun, Yingpu Cui, Chunru Xu...
https://pubmed.ncbi.nlm.nih.gov/35734586/Bin-Shuai Wang, You-Zhao Li, Yang-Yi Fang...
https://pubmed.ncbi.nlm.nih.gov/32898352/Edward Lakatos
https://pubmed.ncbi.nlm.nih.gov/12111882/Zhuo Liu, Qiming Zhang, Xun Zhao...
https://pubmed.ncbi.nlm.nih.gov/34802447/Qiu-Yang Li, Nan Li, Qing-Bo Huang...
https://pubmed.ncbi.nlm.nih.gov/31791422/Lisa C Adams, Bernhard Ralla, Yi-Na Y Bender...
https://pubmed.ncbi.nlm.nih.gov/29724245/Michael Lardas, Fiona Stewart, Duncan Scrimgeour...
https://pubmed.ncbi.nlm.nih.gov/26707869/Masanori Hirono, Mikio Kobayashi, Tomoyasu Tsushima...
https://pubmed.ncbi.nlm.nih.gov/24083566/Peking University Third Hospital
Lead Sponsor